Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy

Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy

Objective [177Lu]Lu-prostate-specific membrane antigen (PSMA)-617 radioligand therapy (RLT) shows promise for metastatic castration-resistant prostate cancer (mCRPC) patients with positive PSMA positron emission tomography (PET) imaging. Identifying high-risk patients is crucial. We evalu...

Full description

Bibliographic Details
Main Authors: Dheeratama Siripongsatian, Attapon Jantarato, Chetsadaporn Promteangtrong, Anchisa Kunawudhi, Peerapon Kiatkittikul, Natphimol Boonkawin, Sukanya Yaset, Sirinsuda Somboon, Chanisa Chotipanich
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-10-01
Series:Indian Journal of Radiology and Imaging
Subjects:
pretherapeutic PSMA PET
metastatic castration-resistant prostate cancer
liver metastasis
[177Lu]Lu-PSMA-617
radioligand therapy
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1779634

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1779634

Similar Items